Literature DB >> 15285293

Pseudomyxoma peritonei usually originates from the appendix: a review of the evidence.

A Mukherjee1, A Parvaiz, T D Cecil, B J Moran.   

Abstract

Pseudomyxoma peritonei (PMP) is a rare condition, said to be more common in females during the fourth or fifth decade of life with an incidence believed to be in the region of one per million per year. Although PMP has been reported as originating from many intra-abdominal organs, in the majority of cases an ovarian or appendix cystadenoma or cystadenocarcinoma has been implicated as the primary site. Our experience suggests that most cases arise from the appendix. We have reviewed the clinical and scientific evidence. In the four largest reported series of 393 patients, 181 (46%) were males. Immunohistochemistry techniques in women with both appendical and ovarian tumours favour an appendiceal primary in most cases. The distinction between "benign" adenomucinosis and mucinous adenocarcinoma is important in both treatment and prognosis. Experience suggests that there may well be a spectrum of disease and possibly an "adenoma carcinoma sequence".

Entities:  

Mesh:

Year:  2004        PMID: 15285293

Source DB:  PubMed          Journal:  Eur J Gynaecol Oncol        ISSN: 0392-2936            Impact factor:   0.196


  28 in total

1.  Pseudomyxoma peritonei.

Authors:  Katharine E Bevan; Faheez Mohamed; Brendan J Moran
Journal:  World J Gastrointest Oncol       Date:  2010-01-15

2.  Controversial origin of Pseudomyxoma peritonei.

Authors:  Alejandro Rojo Sebastián; Francisco José Fernández Morejón; Pedro Bretcha Boix; José Farré Alegre; Jerónimo Forteza Vila; Antonio Brugarolas Masllorens
Journal:  Clin Transl Oncol       Date:  2006-10       Impact factor: 3.405

Review 3.  Peritoneal carcinomatosis of colorectal origin: incidence and current treatment strategies.

Authors:  Manuel J Koppe; Otto C Boerman; Wim J G Oyen; Robert P Bleichrodt
Journal:  Ann Surg       Date:  2006-02       Impact factor: 12.969

4.  Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in the management of pseudomyxoma peritonei: A single-center experience.

Authors:  Ayman Zaki Azzam; Zyad Adil Alyahya; Ahmed Abbas Al Wusaibie; Tarek Mahmoud Amin
Journal:  Indian J Gastroenterol       Date:  2017-11-29

Review 5.  Pseudomyxoma peritonei as an intractable disease and its preoperative assessment to help improve prognosis after surgery: A review of the literature.

Authors:  Yuesi Zhong; Meihai Deng; Ruiyun Xu; Norihiro Kokudo; Wei Tang
Journal:  Intractable Rare Dis Res       Date:  2012-08

6.  Pseudomyxoma peritonei: a rare cause of oliguric acute kidney injury.

Authors:  Hye Sook Min; Jeung Hui Pyo; Eul Sun Moon; Jonghyun Choi; Young Sun Kang; Mi Jin Lee; Jin Joo Cha; Dae Ryong Cha
Journal:  Chonnam Med J       Date:  2013-08-22

7.  Pseudomyxoma peritonei originating from urachus-case report and review of the literature.

Authors:  A K Agrawal; P Bobiński; Z Grzebieniak; J Rudnicki; G Marek; P Kobielak; M Kazanowski; S Agrawal; A Hałoń
Journal:  Curr Oncol       Date:  2014-02       Impact factor: 3.677

8.  Survival analysis of pseudomyxoma peritonei patients treated by cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.

Authors:  Robert M Smeenk; Vic J Verwaal; Ninja Antonini; Frans A N Zoetmulder
Journal:  Ann Surg       Date:  2007-01       Impact factor: 12.969

9.  Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Pseudomyxoma Peritonei and Appendix Tumours.

Authors:  Joshua Lansom; Nayef Alzahrani; Winston Liauw; David L Morris
Journal:  Indian J Surg Oncol       Date:  2015-10-24

10.  Experience with adjuvant chemotherapy for pseudomyxoma peritonei secondary to mucinous adenocarcinoma of the appendix with oxaliplatin/fluorouracil/leucovorin (FOLFOX4).

Authors:  Chin-Fan Chen; Che-Jen Huang; Wan-Yi Kang; Jan-Sing Hsieh
Journal:  World J Surg Oncol       Date:  2008-11-11       Impact factor: 2.754

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.